Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
individual parameter estimate | model-derived value for a specific person's pharmacokinetic parameter | The individual parameter estimate was updated after the second timed measurement. | Assessment | Drug concentrations, exposure and assay interpretation |
infusion-rate history | record of actual rate changes and interruptions before sampling | The infusion-rate history was reconstructed before interpreting the concentration. | Assessment | Medication response, exposure and reconciliation |
interindividual variability | differences in a parameter among different people | The report distinguishes interindividual variability from uncertainty in this patient's estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
intraindividual variability | change in a parameter or result within the same person over time | The repeated levels suggest intraindividual variability across illness episodes. | Assessment | Drug concentrations, exposure and assay interpretation |
intrinsic clearance | capacity of an organ's eliminating machinery independent of flow and binding in the model | The report lists intrinsic clearance as a model parameter. | Assessment | Drug concentrations, exposure and assay interpretation |
levetiracetam | antiseizure medicine measurable in serum or plasma under an appropriate assay | The levetiracetam concentration was collected at a documented interval after the dose. | Objective | Drug levels - named analytes and exposure reports |
limited sampling strategy | specified subset of timed measurements used to estimate an exposure metric | The report names the validated limited sampling strategy used for the AUC estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
matrix effect | influence of other components of the sample on analytical response | The laboratory considered a matrix effect when the results differed by method. | Assessment | Drug concentrations, exposure and assay interpretation |
matrix mismatch | specimen type differs from that assumed by the comparator | A matrix mismatch limits comparison of this plasma result with the whole-blood target. | Assessment | Drug concentrations, exposure and assay interpretation |
measurement unit verification | checking the units attached to a value and to its intended comparator | Perform measurement unit verification before entering the concentration into the note. | Plan | Sampling, laboratory verification and communication |
method comparison | assessment of how results differ between analytical techniques | The method comparison used paired specimens tested on both platforms. | Assessment | Drug concentrations, exposure and assay interpretation |
model fit | agreement between a model and measured observations | Review the model fit against the timed concentrations. | Plan | Drug levels - verification and documentation |
model misspecification | model structure does not adequately describe the observed data | The mismatch between several timed samples raises concern for model misspecification. | Assessment | Drug concentrations, exposure and assay interpretation |
nonlinear kinetics | exposure changes out of proportion to the change in dose | The clinical pharmacist considered nonlinear kinetics when reviewing the concentration trend. | Assessment | Drug levels - exposure and pharmacokinetics |
nonrenal clearance | drug elimination through routes other than the kidneys | The review considered a change in nonrenal clearance during the acute illness. | Assessment | Drug concentrations, exposure and assay interpretation |
observed-to-predicted ratio | measured value divided by the model prediction at that time | The observed-to-predicted ratio was recalculated after the collection time was corrected. | Assessment | Drug concentrations, exposure and assay interpretation |
overdose | quantity taken exceeds the intended dose as established by history or assessment | The history does not establish an overdose from the elevated concentration alone. | Assessment | Medication exposure, response and adverse-effect reasoning |
peripheral draw | collection by peripheral venipuncture | The repeat concentration came from a peripheral draw. | Objective | Drug levels - collection and dose timing |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
population pharmacokinetic model | model of typical drug disposition and its variation across people | The team documented which population pharmacokinetic model informed the estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
posterior estimate | updated model estimate after incorporating observed data | The posterior estimate incorporated the verified sample timing. | Assessment | Drug concentrations, exposure and assay interpretation |
postinfusion | after an infusion has finished | The postinfusion concentration was sampled at the recorded interval after pump stop. | Objective | Drug levels - collection and dose timing |
prediction interval | range intended to cover a future observation under a specified model | The observed concentration was compared with the model's prediction interval. | Assessment | Drug concentrations, exposure and assay interpretation |
procainamide | antiarrhythmic whose active metabolite may also be measured | The procainamide and metabolite concentrations are shown separately. | Objective | Drug levels - named analytes and exposure reports |
protein binding | association of drug with circulating proteins | Altered protein binding limits interpretation of the total concentration alone. | Assessment | Drug levels - exposure and pharmacokinetics |